In a recently published GeroScience paper, “Life-extending interventions do not necessarily result in compression of morbidity: a case example offering a robust statistical approach,” lead author Dr. Deependra Thapa and colleagues asked a fundamental question in aging biology: Do interventions that extend lifespan also shorten the period of morbidity?

To address this, the authors constructed a novel statistical framework—the DIRE (Difference-in-Rate-Effects) method— to rigorously test whether life-extending interventions truly compress morbidity. The method jointly models healthspan and lifespan by comparing the rate of decline in healthspan with the rate of decline in survival toward the end of life. Using three independent mouse datasets, they found that life-extending interventions did not reliably compress morbidity. In some cases, the analyses even suggested morbidity expansion, where animals lived longer but also spent proportionally more time in frailty.

This work highlights a long-standing misconception that lifespan and healthspan necessarily or regularly go hand-in-hand, and suggests that lifespan, healthspan, and morbidity compression are distinct and need to be evaluated separately. Standardizing how researchers quantify compression of morbidity is crucial for evaluating interventions and comparing results across studies. By offering a reproducible quantitative framework, the authors provide geroscientists with a valuable tool for determining under which circumstances “living longer” truly means “living healthier.”